Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stop the Storm!
S&P going to close GREEN... wow
Up a bunch on both... hard to know exactly because I've been in and out. Options for GME commons for HGEN.
I am only posting the comparisons b/c I am amazed that with all the movement of both these stocks they continue to trade neck and neck but have no connection. It's just for fun!
Agreed.
13.77 = 13.77
On radar again... nice news today.
It's a horse race again... Unbelievable!
This is my AR headset play.
What do you think of the VUZI chart?
It's the way I am playing the next MJ run... legit company and management.
Damn we are playing all the same SPACs!
You still in here? I think this deal looks great... market not so much!
Wasn't expecting a down day!!!
Someone is loving the .10s I sold them... still bum hurt about that.
What did you get them at? I am trying to add more too.
My options expire tomorrow. lol!
SRNE on Mad Money tonight... wtf?
Gonna turn green here...
FSLY wish I had some puts... House of Pain!
GME 12 - added weekly 14s and 15s
We need the Mad Money PR now!
VUZI 5 - $5 weekly's still cheap
Delayed reaction?
WTF! That was lame....
News!
That’s HUGE! Finally independent confirmation!!!!
BINGO!
congrats
Dead Heat again... crazy!
Now Dexamethasone. Does that rule out Lenz?
$25 as not a COVID play. What does that mean for price if we get an EUA?
Some buying interest this AM... let's hope this is the start of a new trend!
Who you gonna call? Washington D.C. is going to need a lot of disinfecting.
HGEN volume is baffling to me...
TOMZ - 7.40 looks thin
LENZ has been shown to be safe in clinical settings following administration to 125 patients in multiple indications, including severe respiratory conditions and leukemia, with no serious or adverse events.
Should have been PR Headline.
Humanigen Announces Lenzilumab in COVID-19 Program Updates
Lenzilumab is currently being studied in a phase III trial for
severe and critical COVID-19 pneumonia (NCT04351152) and in the National Institute of Allergy and Infectious Diseases (NIAID) sponsored Big Effect Trial (BET) in combination with remdesivir.
_______________________________________________________________________
Could it be the BET trial has started but HGEN hasn't been greenlighted to announce it?
Lenzulimab could have saved the patient/insurance 10+ weeks of hospital stay. What is that worth?